Publications by authors named "Elise Duhamel"
Article Synopsis
- * Conducted in France from 2018 to 2022, the study found that 13.1% of the 183 patients experienced a NE, with adverse events (AEs) like rheumatism reactivation being the most common.
- * The results suggest that a careful, practitioner-supervised transition to biosimilars can lower the risk of NE, highlighting the importance of shared medical decision-making for effective patient outcomes.
Hypervitanimia B12 is an early marker of serious pathologies. These include solid neoplasms, malignant blood diseases and acute/chronic hepatopathies. Hypervitaminemia B12 in geriatrics is thereby an indicator in the diagnosis and prognosis of these conditions.
View Article and Find Full Text PDF